{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:39:05Z","timestamp":1791927545285,"version":"4.3.4"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01089","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T04:31:48Z","timestamp":1557808308000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Skin Barrier and Autoimmunity\u2014Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin"],"prefix":"10.3389","volume":"10","author":[{"given":"Natalie E.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison J.","family":"Cowin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatko","family":"Kopecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1172\/JCI200524855","article-title":"The pathophysiology of autoimmune blistering diseases","volume":"115","author":"Yancey","year":"2005","journal-title":"J Clin Invest."},{"key":"B2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14734","article-title":"Case of autoimmune intraepidermal and subepidermal blistering disease in which autoantibodies to desmoglein 1 and BP230 coexist","author":"Sugai","year":"2018","journal-title":"J Dermatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/ijms17071116","article-title":"Cytoskeletal regulation of inflammation and its impact on skin blistering disease epidermolysis bullosa acquisita","volume":"17","author":"Kopecki","year":"2016","journal-title":"Int J Mol Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fmed.2018.00296","article-title":"diagnosis of autoimmune blistering diseases","volume":"5","author":"Witte","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3389\/fimmu.2017.00603","article-title":"Mechanisms of autoantibody-induced pathology","volume":"8","author":"Ludwig","year":"2017","journal-title":"Front Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1586\/1744666X.2015.1085801","article-title":"Immune mechanism-targeted treatment of experimental epidermolysis bullosa acquisita","volume":"11","author":"Ludwig","year":"2015","journal-title":"Expert Rev Clin Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fimmu.2019.00034","article-title":"The diagnosis and blistering mechanisms of mucous membrane pemphigoid","volume":"10","author":"Kamaguchi","year":"2019","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"xiii","DOI":"10.1016\/j.iac.2012.04.015","article-title":"Autoimmune diseases of the skin","volume":"32","author":"Murrell","year":"2012","journal-title":"Immunol Allerg Clin North Am."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1002\/cpph.55","article-title":"Drug discovery for pemphigoid diseases","volume":"84","author":"Kasprick","year":"2019","journal-title":"Curr Protoc Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.clindermatol.2011.03.014","article-title":"Current therapy of the pemphigus group","volume":"30","author":"Kasperkiewicz","year":"2012","journal-title":"Clin Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e106895","DOI":"10.1371\/journal.pone.0106895","article-title":"Nanorobotic investigation identifies novel visual, structural and functional correlates of autoimmune pathology in a blistering skin disease model","volume":"9","author":"Seiffert-Sinha","year":"2014","journal-title":"PLoS ONE."},{"key":"B15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fmed.2018.00226","article-title":"The genetics of pemphigus vulgaris","volume":"5","author":"Vodo","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/08820139.2017.1385622","article-title":"Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: a meta-analysis","volume":"47","author":"Li","year":"2018","journal-title":"Immunol Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jdermsci.2017.11.014","article-title":"Association of HLA class I and class II alleles with bullous pemphigoid in Chinese Hans","volume":"89","author":"Fang","year":"2018","journal-title":"J Dermatol Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jid.2017.11.023","article-title":"HLA-DQB1*03:01 as a biomarker for genetic susceptibility to bullous pemphigoid induced by DPP-4 inhibitors","volume":"138","author":"Ujiie","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1038\/jid.2011.231","article-title":"Black patients of African descent and HLA-DRB1*15:03 frequency overrepresented in epidermolysis bullosa acquisita","volume":"131","author":"Zumelzu","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000246282","article-title":"Distribution of HLA class II alleles in Korean patients with epidermolysis bullosa acquisita","volume":"193","author":"Lee","year":"1996","journal-title":"Dermatology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e1006008","DOI":"10.1371\/journal.pgen.1006008","article-title":"Identification of a functional risk variant for pemphigus vulgaris in the ST18 gene","volume":"12","author":"Vodo","year":"2016","journal-title":"PLoS Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/jid.2011.466","article-title":"Identification of quantitative trait loci in experimental epidermolysis bullosa acquisita","volume":"132","author":"Ludwig","year":"2012","journal-title":"J Invest Dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4103\/0378-6323.113111","article-title":"Localized bullous pemphigoid occurring on surgical scars","volume":"79","author":"Sen","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.0303-6987.2004.0188.x","article-title":"Development of pemphigus herpetiformis in a patient with psoriasis receiving UV-light treatment","volume":"31","author":"Sanchez-Palacios","year":"2004","journal-title":"J Cutan Pathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"6053267","DOI":"10.1155\/2017\/6053267","article-title":"Frequency of neurological disorders in bullous pemphigoid patients: a cross-sectional study","volume":"2017","author":"Khosravani","year":"2017","journal-title":"Int Sch Res Notices."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jdv.12995","article-title":"Neurological disorders in patients with bullous pemphigoid: clinical and experimental investigations","volume":"29","author":"Gambichler","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jid.2010.301","article-title":"Risk factors for bullous pemphigoid in the elderly: a prospective case-control study","volume":"131","author":"Bastuji-Garin","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jid.2018.10.010","article-title":"Dermatitis herpetiformis and celiac disease increase the risk of bullous pemphigoid","volume":"139","author":"Varpuluoma","year":"2019","journal-title":"J Invest Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fmed.2018.00238","article-title":"Comorbidities and treatment strategies in bullous pemphigoid: an appraisal of the existing litterature","volume":"5","author":"Bech","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12887-017-0813-0","article-title":"Three case reports of post immunization and post viral Bullous Pemphigoid: looking for the right trigger","volume":"17","author":"Baroero","year":"2017","journal-title":"BMC Pediatr."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0377","DOI":"10.1097\/MD.0000000000010377","article-title":"Bullous pemphigoid associated with chronic hepatitis C virus infection in a hepatitis B virus endemic area: a case report","volume":"97","author":"Jang","year":"2018","journal-title":"Medicine (Baltimore)."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1590\/s1678-9946201759041","article-title":"Refractory pemphigus foliaceus associated with herpesvirus infection: case report","volume":"59","author":"Fernandes","year":"2017","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"B33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D371J1J817","article-title":"Two distinct viral infections complicating pemphigus foliaceus","volume":"18","author":"Gee","year":"2012","journal-title":"Dermatol Online J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000250316","article-title":"Bullous pemphigoid associated with radiotherapy for esophageal carcinoma","volume":"162","author":"Furukawa","year":"1981","journal-title":"Dermatologica"},{"key":"B35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1075-122X.2005.00150.x","article-title":"Radiation therapy as a trigger factor for initially localized bullous pemphigoid","volume":"11","author":"Melani","year":"2005","journal-title":"Breast J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000362208","article-title":"Relationship between radiation therapy and bullous pemphigoid","volume":"229","author":"Nguyen","year":"2014","journal-title":"Dermatology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin Microbiol Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jaut.2007.11.009","article-title":"Cell damage and autoimmunity: a critical appraisal","volume":"30","author":"MacKay","year":"2008","journal-title":"J Autoimmun."},{"key":"B39","first-page":"e9","article-title":"The role of damage-associated molecular patterns in human diseases: part I - promoting inflammation and immunity","volume":"15","author":"Land","year":"2015","journal-title":"Sultan Qaboos Univ Med J"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10495-017-1413-z","article-title":"The immune response to secondary necrotic cells","volume":"22","author":"Sachet","year":"2017","journal-title":"Apoptosis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/exd.12957","article-title":"Update on the role of plasmacytoid dendritic cells in inflammatory\/autoimmune skin diseases","volume":"25","author":"Saadeh","year":"2016","journal-title":"Exp Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jaci.2005.01.047","article-title":"Necrotic cells induce systemic autoimmune disease in vivo by activation of dendritic cells (DCs)","volume":"115","author":"Ma","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1046\/j.1365-2230.2001.00852.x","article-title":"Epitope spreading: protection from pathogens, but propagation of autoimmunity?","volume":"26","author":"Powell","year":"2001","journal-title":"Clin Exp Dermatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1087-0024.2004.00833.x","article-title":"Environmental risk factors in endemic pemphigus foliaceus (fogo selvagem)","volume":"9","author":"Aoki","year":"2004","journal-title":"J Investig Dermatol Symp Proc."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.1200842","article-title":"Cutting Edge: Brazilian pemphigus foliaceus anti-desmoglein 1 autoantibodies cross-react with sand fly salivary LJM11 antigen","volume":"189","author":"Qian","year":"2012","journal-title":"J Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/CCID.S100802","article-title":"Paraneoplastic pemphigus: a short review","volume":"9","author":"Wieczorek","year":"2016","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1001\/archderm.136.5.663","article-title":"Epitope spreading in paraneoplastic pemphigus: autoimmune induction in antibody-mediated blistering skin diseases","volume":"136","author":"Chan","year":"2000","journal-title":"Arch Dermatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4103\/0019-5154.135493","article-title":"Association of bullous pemphigoid with malignancy: a myth or reality?","volume":"59","author":"Fernandes","year":"2014","journal-title":"Indian J Dermatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4103\/0022-3859.150906","article-title":"A case of paraneoplastic bullous pemphigoid in association with squamous cell carcinoma of lung","volume":"61","author":"Das","year":"2015","journal-title":"J Postgrad Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijscr.2014.02.008","article-title":"Dramatic resolution of bullous pemphigoid after surgery for gastric cancer: a case report","volume":"5","author":"Noguchi","year":"2014","journal-title":"Int J Surg Case Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/1346-8138.13079","article-title":"Malignancies in bullous pemphigoid: a controversial association","volume":"43","author":"Balestri","year":"2016","journal-title":"J Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamadermatol.2014.5263","article-title":"Association of bullous pemphigoid and malignant neoplasms","volume":"151","author":"Cai","year":"2015","journal-title":"JAMA Dermatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3389\/fimmu.2018.00779","article-title":"Humoral epitope spreading in autoimmune bullous diseases","volume":"9","author":"Didona","year":"2018","journal-title":"Front Immunol."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20142966","article-title":"Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment","author":"Clarindo","year":"2014","journal-title":"An Bras Dermatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/archderm.136.2.227","article-title":"Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3","volume":"136","author":"Jonkman","year":"2000","journal-title":"Arch Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1038\/jid.2011.180","article-title":"Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study","volume":"131","author":"Di Zenzo","year":"2011","journal-title":"J Invest Dermatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1001\/jamadermatol.2018.2352","article-title":"Association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors in patients with diabetes: estimating the risk of the new agents and characterizing the patients","volume":"154","author":"Kridin","year":"2018","journal-title":"JAMA Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B59","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000443330","article-title":"Three cases of bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors - one due to linagliptin","volume":"232","author":"Mendonca","year":"2016","journal-title":"Dermatology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1016\/j.jid.2016.06.622","article-title":"Autoantibody profile differentiates between inflammatory and noninflammatory bullous pemphigoid","volume":"136","author":"Izumi","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-017-0336-3","article-title":"Dermatologic reactions to immune checkpoint inhibitors : skin toxicities and immunotherapy","volume":"19","author":"Sibaud","year":"2018","journal-title":"Am J Clin Dermatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fmed.2018.00268","article-title":"Mucous membrane pemphigoid, bullous pemphigoid, and anti-programmed death-1\/ programmed death-ligand 1: a case report of an elderly woman with mucous membrane pemphigoid developing after pembrolizumab therapy for metastatic melanoma and review of the literature","volume":"5","author":"Zumelzu","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1172\/JCI65938","article-title":"T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies","volume":"123","author":"Hess","year":"2013","journal-title":"J Clin Invest."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1084\/jem.20040168","article-title":"Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB\/W mice","volume":"199","author":"Hoyer","year":"2004","journal-title":"J Exp Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"175ra30","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","article-title":"Long-lived autoreactive plasma cells drive persistent autoimmune inflammation","volume":"7","author":"Hiepe","year":"2011","journal-title":"Nat Rev Rheumatol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneph.2016.20","article-title":"Plasma cells as an innovative target in autoimmune disease with renal manifestations","volume":"12","author":"Hiepe","year":"2016","journal-title":"Nat Rev Nephrol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fimmu.2018.00622","article-title":"B cell modulation strategies in autoimmune diseases: new concepts","volume":"9","author":"Musette","year":"2018","journal-title":"Front Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e83631","DOI":"10.1371\/journal.pone.0083631","article-title":"Persistent autoantibody-production by intermediates between short-and long-lived plasma cells in inflamed lymph nodes of experimental epidermolysis bullosa acquisita","volume":"8","author":"Tiburzy","year":"2013","journal-title":"PLoS ONE."},{"key":"B70","doi-asserted-by":"publisher","first-page":"7151285","DOI":"10.1155\/2017\/7151285","article-title":"Th1\/Th17-related cytokines and chemokines and their implications in the pathogenesis of pemphigus vulgaris","volume":"2017","author":"Timoteo","year":"2017","journal-title":"Mediators Inflamm."},{"key":"B71","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5021\/ad.2017.29.4.438","article-title":"Analysis of serum cytokine profile in pemphigus","volume":"29","author":"Lee","year":"2017","journal-title":"Ann Dermatol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/cei.12566","article-title":"T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid","volume":"180","author":"Pickford","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.clim.2006.03.014","article-title":"Increased expression of Th2-associated chemokines in bullous pemphigoid disease","volume":"120","author":"Gounni Abdelilah","year":"2006","journal-title":"Clin Immunol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"642","DOI":"10.2340\/00015555-2604","article-title":"Increased serum levels of Th2-type cytokines and eotaxin in fibrillar-type dermatitis herpetiformis","volume":"97","author":"Makino","year":"2017","journal-title":"Acta Derm Venereol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.3389\/fimmu.2017.01628","article-title":"Regulatory T cells suppress inflammation and blistering in pemphigoid diseases","volume":"8","author":"Bieber","year":"2017","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000099585","article-title":"CD4+CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris","volume":"214","author":"Sugiyama","year":"2007","journal-title":"Dermatology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.4049\/jimmunol.172.10.6468","article-title":"Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris","volume":"172","author":"Veldman","year":"2004","journal-title":"J Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/intimm\/dxr020","article-title":"Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris","volume":"23","author":"Yokoyama","year":"2011","journal-title":"Int Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1016\/j.jid.2017.05.032","article-title":"Pivotal role of lesional and perilesional T\/B lymphocytes in pemphigus pathogenesis","volume":"137","author":"Yuan","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","article-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","volume":"306","author":"Anhalt","year":"1982","journal-title":"N Engl J Med."},{"key":"B81","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1046\/j.1523-1747.1999.00585.x","article-title":"The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic","volume":"112","author":"Ding","year":"1999","journal-title":"J Invest Dermatol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1172\/JCI3647","article-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","volume":"102","author":"Amagai","year":"1998","journal-title":"J Clin Invest."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/sj.jid.5700254","article-title":"Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients","volume":"126","author":"Woodley","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fmed.2018.00201","article-title":"The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy"},{"key":"B86","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3389\/fimmu.2018.00407","article-title":"The autoimmune skin disease bullous pemphigoid: the role of mast cells in autoantibody-induced tissue injury","volume":"9","author":"Fang","year":"2018","journal-title":"Front Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3389\/fimmu.2018.00386","article-title":"The role of mast cells in autoimmune bullous dermatoses","volume":"9","author":"Yu","year":"2018","journal-title":"Front Immunol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/eji.201646723","article-title":"IL-17 and IL-22 in immunity: driving protection and pathology","volume":"47","author":"Eyerich","year":"2017","journal-title":"Eur J Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jaci.2018.04.006","article-title":"Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease","volume":"142","author":"Haeberle","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.jaci.2018.08.028","article-title":"Regulatory T-cell deficiency and autoimmune skin disease: Beyond the scurfy mouse and immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome","volume":"142","author":"Hashimoto","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/eji.200838190","article-title":"Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15","volume":"38","author":"Yang","year":"2008","journal-title":"Eur J Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S0923-1811(99)00016-X","article-title":"Autoimmunity against desmosomal cadherins in pemphigus","volume":"20","author":"Amagai","year":"1999","journal-title":"J Dermatol Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1172\/JCI23475","article-title":"Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction","volume":"115","author":"Waschke","year":"2005","journal-title":"J Clin Invest."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.2353\/ajpath.2008.080391","article-title":"Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin","volume":"173","author":"Berkowitz","year":"2008","journal-title":"Am J Pathol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1523-1747.1999.00463.x","article-title":"Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells","volume":"112","author":"Aoyama","year":"1999","journal-title":"J Invest Dermatol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"23826","DOI":"10.1074\/jbc.M115.668061","article-title":"Critical role of the neonatal Fc receptor (FcRn) in the pathogenic action of antimitochondrial autoantibodies synergizing with anti-desmoglein autoantibodies in pemphigus vulgaris","volume":"290","author":"Chen","year":"2015","journal-title":"J Biol Chem."},{"key":"B97","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/0019-5154.198032","article-title":"Autoantibodies other than anti-desmogleins in pemphigus vulgaris patients","volume":"62","author":"Saleh","year":"2017","journal-title":"Indian J Dermatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3389\/fimmu.2018.01190","article-title":"Non-desmoglein antibodies in patients with pemphigus vulgaris","volume":"9","author":"Amber","year":"2018","journal-title":"Front Immunol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0002-9440(10)64651-2","article-title":"Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity","volume":"157","author":"Nguyen","year":"2000","journal-title":"Am J Pathol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3109\/08916934.2011.606444","article-title":"Pemphigus autoimmunity: hypotheses and realities","volume":"45","author":"Grando","year":"2012","journal-title":"Autoimmunity"},{"key":"B101","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fimmu.2018.00692","article-title":"Autoantibody signaling in pemphigus vulgaris: development of an integrated model","volume":"9","author":"Sajda","year":"2018","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3389\/fimmu.2018.02687","article-title":"Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients","volume":"9","author":"Chiorean","year":"2018","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jid.2017.09.026","article-title":"Increasing the complement of therapeutic options in bullous pemphigoid","volume":"138","author":"Kushner","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jid.2017.11.031","article-title":"Eosinophils mediate tissue injury in the autoimmune skin disease bullous pemphigoid","volume":"138","author":"Lin","year":"2018","journal-title":"J Invest Dermatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.4049\/jimmunol.1400095","article-title":"Bullous pemphigoid autoantibodies directly induce blister formation without complement activation","volume":"193","author":"Ujiie","year":"2014","journal-title":"J Immunol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/jid.2008.305","article-title":"IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment","volume":"129","author":"Iwata","year":"2009","journal-title":"J Invest Dermatol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jid.2017.08.030","article-title":"The anti-C1s antibody TNT003 prevents complement activation in the skin induced by bullous pemphigoid autoantibodies","volume":"138","author":"Kasprick","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","article-title":"Mechanisms of disease: pemphigus and bullous pemphigoid","volume":"11","author":"Hammers","year":"2016","journal-title":"Annu Rev Pathol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fimmu.2018.00535","article-title":"Specific inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice","volume":"9","author":"Mihai","year":"2018","journal-title":"Front Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.4049\/jimmunol.178.10.6514","article-title":"The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita","volume":"178","author":"Mihai","year":"2007","journal-title":"J Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0002-9440(10)64182-X","article-title":"Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin","volume":"161","author":"Sitaru","year":"2002","journal-title":"Am J Pathol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"38357","DOI":"10.1038\/srep38357","article-title":"T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita","volume":"6","author":"Bieber","year":"2016","journal-title":"Sci Rep."},{"key":"B113","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/ijdpdd.ijdpdd_22_18","article-title":"The utility of tissue and epidermal transglutaminase immunohistochemistry in dermatitis herpetiformis","volume":"5","author":"Valencia-Guerrero","year":"2018","journal-title":"Indian J Dermatopathol Diagn Dermatol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/07853890.2016.1222450","article-title":"Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease","volume":"49","author":"Collin","year":"2017","journal-title":"Ann Med."},{"key":"B115","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jdermsci.2014.11.003","article-title":"Regulatory T cells as well as IL-10 are reduced in the skin of patients with dermatitis herpetiformis","volume":"77","author":"Antiga","year":"2015","journal-title":"J Dermatol Sci."},{"key":"B116","first-page":"622","article-title":"Where does rituximab fit in the treatment of autoimmune mucocutaneous blistering skin disease?","volume":"11","author":"Nigam","year":"2012","journal-title":"J Drugs Dermatol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","article-title":"IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid","volume":"96","author":"Chakievska","year":"2019","journal-title":"J Autoimmun."},{"key":"B118","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/JID.2015.356","article-title":"Epidermolysis bullosa acquisita: from pathophysiology to novel therapeutic options","volume":"136","author":"Kasperkiewicz","year":"2016","journal-title":"J Invest Dermatol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3389\/fimmu.2018.01558","article-title":"Therapeutic effect of a novel phosphatidylinositol-3-kinase delta inhibitor in experimental epidermolysis bullosa acquisita","volume":"9","author":"Koga","year":"2018","journal-title":"Front Immunol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3389\/fmed.2018.00306","article-title":"Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference","volume":"5","author":"Lee","year":"2018","journal-title":"Front Med (Lausanne)."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/exd.13335","article-title":"Signalling and targeted therapy of inflammatory cells in epidermolysis bullosa acquisita","volume":"26","author":"Ludwig","year":"2017","journal-title":"Exp Dermatol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jid.2017.09.009","article-title":"Calcitriol treatment ameliorates inflammation and blistering in mouse models of epidermolysis bullosa acquisita","volume":"138","author":"Tukaj","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1517\/14728222.2016.1148686","article-title":"Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisita","volume":"20","author":"Witte","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/bjd.15930","article-title":"British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017","volume":"177","author":"Harman","year":"2017","journal-title":"Br J Dermatol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/bjd.12072","article-title":"British Association of Dermatologists' guidelines for the management of bullous pemphigoid 2012","volume":"167","author":"Venning","year":"2012","journal-title":"Br J Dermatol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0140-6736(17)30070-3","article-title":"First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial","volume":"389","author":"Joly","year":"2017","journal-title":"Lancet."},{"key":"B127","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1046\/j.1365-2133.2000.03328.x","article-title":"Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris","volume":"142","author":"Proby","year":"2000","journal-title":"Br J Dermatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/TCRM.S142471","article-title":"Emerging treatment options for the management of pemphigus vulgaris","volume":"14","author":"Kridin","year":"2018","journal-title":"Therap Clin Risk Manage"},{"key":"B129","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jdermsci.2016.11.003","article-title":"A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid","volume":"85","author":"Amagai","year":"2017","journal-title":"J Dermatol Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2119\/molmed.2015.00206","article-title":"Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment","volume":"22","author":"Hirose","year":"2017","journal-title":"Mol Med."},{"key":"B131","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fimmu.2017.00484","article-title":"Eosinophils in autoimmune diseases","volume":"8","author":"Diny","year":"2017","journal-title":"Front Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s004030050252","article-title":"Electron microscopy and morphometry enhances differentiation of epidermolysis bullosa subtypes","volume":"289","author":"Jaunzems","year":"1997","journal-title":"Arch Dermatol Res"},{"key":"B133","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2249.2011.04464.x","article-title":"Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid","volume":"166","author":"Gunther","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1385\/1-59259-332-1:255","article-title":"Suction blister model of wound healing","volume":"78","author":"Koivukangas","year":"2003","journal-title":"Methods Mol Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jid.2016.08.032","article-title":"Topically applied Hsp90 blocker 17AAG inhibits autoantibody-mediated blister-inducing cutaneous inflammation","volume":"137","author":"Tukaj","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"6135","DOI":"10.1182\/blood-2010-10-314609","article-title":"Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets","volume":"117","author":"Kasperkiewicz","year":"2011","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fimmu.2018.00249","article-title":"Whole-genome expression profiling in skin reveals SYK As a key regulator of inflammation in experimental epidermolysis bullosa acquisita","volume":"9","author":"Samavedam","year":"2018","journal-title":"Front Immunol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/j.oooo.2018.02.085","article-title":"Therapeutic success of vitamin D replacement in oral pemphigus vulgaris: a case report","volume":"126","author":"Costa Arantes","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/jid.2012.457","article-title":"Topically applied flightless i neutralizing antibodies improve healing of blistered skin in a murine model of epidermolysis bullosa acquisita","volume":"133","author":"Kopecki","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1001\/jamadermatol.2016.4676","article-title":"Rituximab treatment for recalcitrant dermatitis herpetiformis","volume":"153","author":"Albers","year":"2017","journal-title":"JAMA Dermatol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CCID.S69127","article-title":"The diagnosis and treatment of dermatitis herpetiformis","volume":"8","author":"Antiga","year":"2015","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.jaad.2016.01.020","article-title":"Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP)","volume":"74","author":"Maley","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/QCO.0000000000000279","article-title":"Infections associated with the use of eculizumab: recommendations for prevention and prophylaxis","volume":"29","author":"Benamu","year":"2016","journal-title":"Curr Opin Infect Dis."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e003573","DOI":"10.1136\/bmjopen-2013-003573","article-title":"A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)","volume":"3","author":"Rathbone","year":"2013","journal-title":"BMJ Open."},{"key":"B145","first-page":"245","article-title":"Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist etanercept","volume":"74","author":"Berookhim","year":"2004","journal-title":"Cutis"},{"key":"B146","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.4049\/jimmunol.1402688","article-title":"Caspase-1-independent IL-1 release mediates blister formation in autoantibody-induced tissue injury through modulation of endothelial adhesion molecules","volume":"194","author":"Sadeghi","year":"2015","journal-title":"J Immunol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"522","DOI":"10.4049\/jimmunol.164.1.522","article-title":"Immune modulation in pemphigus vulgaris: role of CD28 and IL-10","volume":"164","author":"Toto","year":"2000","journal-title":"J Immunol."},{"key":"B148","first-page":"203","article-title":"Transforming growth factor-beta promotes deposition of collagen VII in a modified organotypic skin model","volume":"70","author":"Konig","year":"1994","journal-title":"Lab Invest"},{"key":"B149","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0006-291X(05)81118-0","article-title":"Transforming growth factor-beta up-regulates type VII collagen gene expression in normal and transformed epidermal keratinocytes in culture","volume":"180","author":"Ryynanen","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"B150","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1007\/s00403-002-0370-7","article-title":"Epidermolysis bullosa: directions for future research and new challenges for treatment","volume":"295","author":"Sawamura","year":"2003","journal-title":"Arch Dermatol Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"9259646","DOI":"10.1155\/2016\/9259646","article-title":"Biologics for targeting inflammatory cytokines, clinical uses, and limitations","volume":"2016","author":"Rider","year":"2016","journal-title":"Int J Cell Biol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ebiom.2017.12.022","article-title":"Langerhans cells prevent autoimmunity via expansion of keratinocyte antigen-specific regulatory T cells","volume":"27","author":"Kitashima","year":"2018","journal-title":"EBioMedicine"},{"key":"B153","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.4049\/jimmunol.1300310","article-title":"B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita","volume":"191","author":"Iwata","year":"2013","journal-title":"J Immunol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"559","DOI":"10.4049\/jimmunol.1301556","article-title":"GM-CSF modulates autoantibody production and skin blistering in experimental epidermolysis bullosa acquisita","volume":"192","author":"Samavedam","year":"2014","journal-title":"J Immunol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"8980534","DOI":"10.1155\/2017\/8980534","article-title":"Correlation between IL36alpha and IL17 and Activity of the disease in selected autoimmune blistering diseases","volume":"2017","author":"Zebrowska","year":"2017","journal-title":"Mediators Inflamm"},{"key":"B156","doi-asserted-by":"publisher","first-page":"764290","DOI":"10.1155\/2013\/764290","article-title":"A possible role for CD8+ T lymphocytes in the cell-mediated pathogenesis of pemphigus vulgaris","volume":"2013","author":"Giurdanella","year":"2013","journal-title":"Mediators Inflamm."},{"key":"B157","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ijwd.2015.01.002","article-title":"Autoimmune blistering diseases in females: a review","volume":"1","author":"Zhao","year":"2015","journal-title":"Int J Womens Dermatol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"6061825","DOI":"10.1155\/2018\/6061825","article-title":"Autoimmune diseases and their manifestations on oral cavity: diagnosis and clinical management","volume":"2018","author":"Saccucci","year":"2018","journal-title":"J Immunol Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01089\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T23:56:24Z","timestamp":1663458984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01089\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":159,"alternative-id":["10.3389\/fimmu.2019.01089"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01089","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"article-number":"1089"}}